Alan Thomas Remaley MD, PhD, FAHA

Dr. Alan Remaley is the section chief of the Lipoprotein Metabolism Laboratory in the Translational Vascular Medicine Branch of the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, Maryland. He is also a senior staff member of the Department of Laboratory Medicine at the National Institutes of Health Clinical Center.

Dr. Remaley received his BS in biochemistry and chemistry from the University of Pittsburgh in 1981. In 1987, he received an MD and PhD (biochemistry) from the University of Pittsburgh and completed in 1990 a residency in clinical pathology at the University of Pennsylvania. He did a post-doctoral fellowship with Dr. Bryan Brewer at NHLBI from 1990 to 1995.

He has been the recipient of many awards for his research and reached the rank of Captain in the United States Public Health Service before he joined the civil service in 2014. He has published more than 500 papers in the field of lipoprotein metabolism and cardiovascular disease. In addition, he is an inventor on multiple patents related to new therapeutic agents and diagnostic tests for cardiovascular disease. The central focus of Dr. Remaley’s research is lipoprotein metabolism and its role in cardiovascular disease. As a physician-scientist, he uses a multidisciplinary approach to translate basic science findings into new therapies or diagnostics.